Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice
Open Access
- 1 December 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 25 (12) , 2361-2372
- https://doi.org/10.1093/carcin/bgh271
Abstract
The vitamin D3 receptor (VDR) is a ligand-dependent transcription factor implicated in regulation of cell cycle, differentiation and apoptosis of both normal and transformed cells derived from mammary gland. In these studies we examined whether VDR status altered mammary gland morphology or transformation in the well-characterized MMTV-neu transgenic model of breast cancer. We demonstrate that VDR protein is highly expressed in neu-positive epithelial cells of preneoplastic lesions, established tumors and lung metastases from MMTV-neu mice. Furthermore, MMTV-neu mice lacking VDR exhibit abnormal mammary ductal morphology characterized by dilated, distended ducts containing dysplastic epithelial cells. From 12 months of age on, MMTV-neu mice lacking VDR also experience body weight loss, atrophy of the mammary fat pad, estrogen deficiency and reduced survival. The limited survival of MMTV-neu mice lacking VDR precluded an accurate assessment of the impact of complete VDR ablation on tumor development. MMTV-neu mice heterozygous for VDR, however, did not exhibit body weight loss, mammary gland atrophy or compromised survival. Compared with MMTV-neu mice with two copies of the VDR gene, haploinsufficiency of VDR shortened the latency and increased the incidence of mammary tumor formation. Tumor histology and expression/subcellular localization of the neu transgene were not altered by VDR haploinsufficiency despite a significant decrease in tumor VDR expression. Collectively, these studies suggest that VDR gene dosage impacts on age-related changes in ductal morphology and oncogene-induced tumorigenesis of the mammary gland in vivo.Keywords
This publication has 54 references indexed in Scilit:
- Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer CellsJournal of Biological Chemistry, 2001
- SUM-159PT cells: a novel estrogen independent human breast cancer model systemBreast Cancer Research and Treatment, 1999
- EFFECTS OF 1α,25‐DIHYDROXYCHOLECALCIFEROL AND CORTISOL ON THE GROWTH AND DIFFERENTIATION OF PRIMARY CULTURES OF MOUSE MAMMARY EPITHELIAL CELLS IN COLLAGEN GELCell Biology International, 1999
- Apoptotic Regression of MCF-7 Xenografts in Nude Mice Treated with the Vitamin D3Analog, EB10891Endocrinology, 1998
- Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cellsOncogene, 1997
- 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089European Journal Of Cancer, 1996
- Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.Genes & Development, 1996
- Influence of tumor derived fibroblasts and 1,25-dihydroxyvitamin D3 on growth of breast cancer cell linesBreast Cancer Research and Treatment, 1995
- POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATIONThe Lancet, 1989